High glucose and diabetes enhanced store-operated Ca2+ entry and increased expression of its signaling proteins in mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 306, Issue 9, 2014, Pages

  Chaudhari, Sarika ^a   Wu, Peiwen ^b   Wang, Yanxia ^a   Ding, Yanfeng ^a   Yuan, Joseph ^a   Begg, Malcolm ^c   Ma, Rong ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Diabetic nephropathy; High glucose; Mesangial cells; Orai1; STIM1

Indexed keywords

CALCIUM CHANNEL; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CYCLOPIAZONIC ACID; G PROTEIN COUPLED RECEPTOR; GLUCOSE; INOSITOL 1,4,5 TRISPHOSPHATE; MESSENGER RNA; STROMAL INTERACTION MOLECULE 1; STROMAL INTERACTION MOLECULE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

DIABETIC NEPHROPATHY; HIGH GLUCOSE; MESANGIAL CELLS; ORAI1; STIM1; STORE-OPERATED CA2+ ENTRY;

ANIMALS; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM SIGNALING; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GLUCOSE; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; ION CHANNEL GATING; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MESANGIAL CELLS; NEOPLASM PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84900533240     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00463.2013     Document Type: Article

References (88)

1. Abboud HE. Mesangial cell biology. Exp Cell Res 318: 979-985, 2012.
2. Ashmole I, Duffy SM, Leyland ML, Morrison VS, Begg M, Bradding P. CRACM/Orai ion channel expression and function in human lung mast cells. J Allergy Clin Immunol 129: 1628-1635, 2012.
3. 2+ entry through its constitutive and inducible movement in the endoplasmic reticulum. Proc Natl Acad Sci USA 103: 16704-16709, 2006.
4. 2+ block of the store-operated calcium current ICRAC in rat basophilic leukaemia cells. Pflügers Arch 443: 892-902, 2002.
5. Bakowski D, Parekh AB. Permeation through store-operated CRAC channels in divalent-free solution: potential problems and implications for putative CRAC channel genes. Cell Calcium 32: 379-391, 2002.
6. Banday AA, Fazili FR, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and hypertension via mechanisms that involve nuclear factor-kB and protein kinase C. J Am Soc Nephrol 18: 1446-1457, 2007.
7. Bird GS, Dehaven WI, Smyth JT, Putney JW Jr. Methods for studying store-operated calcium entry. Methods 46: 204-212, 2008.
8. 2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin. J Physiol (Lond) 517: 121-134, 1999.
9. Campos AH, Calixto JB, Schor N. Bradykinin induces a calcium-storedependent calcium influx in mouse mesangial cells. Nephron 91: 308-315, 2002.
10. 2+]i responses to ANG II. Am J Physiol Renal Physiol 288: F658-F664, 2005.
11. Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int 68: 2562-2571, 2005.
12. Deng X, Wang Y, Zhou Y, Soboloff J, Gill DL. STIM and Orai-dynamic intermembrane coupling to control cellular calcium signals. J Biol Chem 284: 22501-22505, 2009.
13. Derler I, Schindl R, Fritsch R, Heftberger P, Riedl MC, Begg M, House D, Romanin C. The action of selective CRAC channel blockers is affected by the Orai pore geometry. Cell Calcium 53: 139-151, 2013.
14. Dietrich A, Gudermann T. TRPC6. Handb Exp Pharmacol 179: 125-141, 2007.
15. 2+ signaling by polycystin 2 in glomerular mesangial cells. Am J Physiol Renal Physiol 294: F909-F918, 2008.
16. Du J, Sours-Brothers S, Coleman R, Ding M, Graham S, Kong D, Ma R. Canonical transient receptor potential 1 channel is involved in contractile function of glomerular mesangial cells. J Am Soc Nephrol 18: 1437-1445, 2007.
17. 2+ entry and affect cellular functions. J Biol Chem 287: 2719-2730, 2012.
18. 2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin. Am J Physiol Renal Physiol 288: F545-F551, 2005.
19. 2+exchange. Am J Physiol Renal Physiol 294: F212-F219, 2008.
20. 2+ signaling in rat afferent arterioles: stimulation of cyclic ADP ribose and IP3 pathways. Am J Physiol Renal Physiol 288: F785-F791, 2005.
21. 2+ entry is exaggerated in fresh preglomerular vascular smooth muscle cells of SHR. Kidney Int 61: 2132-2141, 2002.
22. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179-185, 2006.
23. 2+ signaling in high glucose is due to inactivation of phospholipase C-β3 by protein kinase C. Am J Physiol Renal Physiol 289: F1078-F1087, 2005.
24. Gaikwad AB, Gupta J, Tikoo K. Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions. Biochem J 432: 333-341, 2010.
25. 2+ channel blockade as a potential tool in antipancreatitis therapy. Proc Natl Acad Sci USA 110: 13186-13191, 2013.
26. 2+ signaling in glomerular mesangial cells. Am J Physiol Renal Physiol 293: F1381-F1390, 2007.
27. Graham S, Gorin Y, Abboud HE, Ding M, Lee DY, Shi H, Ding Y, Ma R. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Am J Physiol Cell Physiol 301: C304-C315, 2011.
28. Gruden G, Setti G, Hayward A, Sugden D, Duggan S, Burt D, Buckingham RE, Gnudi L, Viberti G. Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol 16: 688-696, 2005.
29. Ha H, Yu M, Kim KH. Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radic Biol Med 26: 944-950, 1999.
30. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB. Role of high glucoseinduced nuclear factor-_B activation in monocyte chemoattractant protein- 1 expression by mesangial cells. J Am Soc Nephrol 13: 894-902, 2002.
31. 2+ channels in human glomerular mesangial cells. Am J Physiol Renal Physiol 278: F97-F103, 2000.
32. Hewavitharana T, Deng X, Soboloff J, Gill DL. Role of STIM and Orai proteins in the store-operated calcium signaling pathway. Cell Calcium 42: 173-182, 2007.
33. Hoth M, Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355: 353-356, 1992.
34. Hoth M, Penner R. Calcium release-activated calcium current in rat mast cells. J Physiol (Lond) 465: 359-386, 1993.
35. Hulot JS, Fauconnier J, Ramanujam D, Chaanine A, Aubart F, Sassi Y, Merkle S, Cazorla O, Ouillé A, Dupuis M, Hadri L, Jeong D, Mühlstedt S, Schmitt J, Braun A, Bénard L, Saliba Y, Laggerbauer B, Nieswandt B, Lacampagne A, Hajjar RJ, Lompré AM, Engelhardt S. Critical role for stromal interaction molecule 1 in cardiac hypertrophy. Circulation 124: 796-805, 2011.
36. Iwamoto M, Mizuiri S, Arita M, Hemmi H. Nuclear factor-κB activation in diabetic rat kidney: evidence for involvement of P-selectin in diabetic nephropathy. Tohoku J Exp Med 206: 163-171, 2005.
37. Kanwar YS, Akagi S, Sun L, Nayak B, Xie P, Wada J, Chugh SS, Danesh FR. Cell biology of diabetic kidney disease. Nephron Exp Nephrol 101: e100-e110, 2005.
38. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 233: 4-11, 2008.
39. Kashgarian M, Sterzel RB. The pathobiology of the mesangium. Kidney Int 41: 524-529, 1992.
40. Kikkawa R, Kitamura E, Fujiwara Y, Arimura T, Haneda M, Shigeta Y. Impaired contractile responsiveness of diabetic glomeruli to angiotensin II: a possible indication of mesangial dysfunction in diabetes mellitus. Biochem Biophys Res Commun 136: 1185-1190, 1986.
41. Lee JE, Jeon IS, Han NE, Song HJ, Kim EG, Choi JW, Song KD, Lee HK, Choi JK. Ubiquilin 1 interacts with Orai1 to regulate calcium mobilization. Mol Cells 35: 41-46, 2013.
42. Lewis RS. The molecular choreography of a store-operated calcium channel. Nature 446: 284-287, 2007.
43. 2+ channels through an IP3 independent pathway in human glomerular mesangial cells. J Biol Chem 279: 4570-4577, 2004.
44. Liao Y, Erxleben C, Abramowitz J, Flockerzi V, Zhu MX, Armstrong DL, Birnbaumer L. Functional interactions among orai1, TRPCs, and STIM1 suggest a STIM-regulated heteromeric Orai/TRPC model for SOCE/Icrac channels. Proc Natl Acad Sci USA 105: 2895-2900, 2008.
45. 2+ influx. Curr Biol 15: 1235-1241, 2005.
46. Luan JJ, Li W, Han J, Zhang W, Gong W, Ma R. Renal protection of in vivo administration of tempol in streptozotocin-induced diabetic rats. J Pharmacol Sci 119: 167-176, 2012.
47. Ma R, Pluznick JL, Sansom SC. Ion channels in mesangial cells: function, malfunction, or fiction. Physiology 20: 102-111, 2005.
48. Ma R, Sansom SC. Epidermal growth factor activates store-operated calcium channels in human glomerular mesangial cells. J Am Soc Nephrol 12: 47-53, 2001.
49. 2+ channels in human glomerular mesangial cells. Am J Physiol Renal Physiol 278: F954-F961, 2000.
50. Mancarella S, Potireddy S, Wang Y, Gao H, Gandhirajan RK, Autieri M, Scalia R, Cheng Z, Wang H, Madesh M, Houser SR, Gill DL. Targeted STIM deletion impairs calcium homeostasis, NFAT activation, and growth of smooth muscle. FASEB J 27: 893-906, 2013.
51. 2+ signaling of cultured human mesangial cells. J Am Soc Nephrol 10: 1478-1486, 1999.
52. 2+ influx in cultured rat mesangial cells by a protein kinase C-dependent mechanism. Diabetologia 40: 521-527, 1997.
53. Menè P, Pugliese G, Pricci F, DiMario V, Cinotti GA, Pugliese F. High glucose inhibits cytosolic calcium signaling in cultured rat mesangial cells. Kidney Int 43: 585-591, 1993.
54. Menè P, Simonson MS, Dunn MJ. Physiology of mesangial cell. Physiol Rev 69: 1347-1424, 1989.
55. Menè P, Teti A, Pugliese F, Cinotti GA. Calcium release-activated calcium influx in cultured human mesangial cells. Kidney Int 46: 122-128, 1994.
56. Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, Schneider H, Ruiz-Ortega M, Egido J. NF-κB activation and overexpression of regulated gene in human diabetic nephropathy. Nephrol Dial Transplant 19: 2505-2512, 2004.
57. Misra RP. Isolation of glomeruli from mammalian kidneys by graded sieving. Am J Clin Pathol 58: 135-139, 1972.
58. Nutt LK, O'Neil RG. Effect of elevated glucose on endothelin-induced store-operated and non-store-operated calcium influx in renal mesangial cells. J Am Soc Nephrol 11: 1225-1235, 2000.
59. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol Rev 85: 757-810, 2005.
60. 2+ entry constrains tuberous sclerosis complex-related tumor development. Oncogene 32: 4702-4711, 2013.
61. Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan PG. Orail1 is an essential pore subunit of the CRAC channel. Nature 443: 230-233, 2006.
62. 2+-inhibited cation (MIC) channels. J Gen Physiol 119: 487-508, 2002.
63. Putney JW Jr. Recent breakthroughs in the molecular mechanism of capacitative calcium entry (with thoughts on how we got here). Cell Calcium 42: 103-110, 2007.
64. Putney JW Jr. A model for receptor-regulated calcium entry. Cell Calcium 7: 1-12, 1986.
65. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Reaven GM. A new rat model of type 2 diabetes: the fat-fed, streptozotocintreated rat. Metabolism 49: 1390-1394, 2000.
66. Rice LV, Bax HJ, Russell LJ, Barrett VJ, Walton SE, Deakin AM, Thomson SA, Lucas F, Solari R, Hous D, Begg M. Characterization of selective calcium-release activated calcium channel blockers in mast cells and T-cells from human, rat, mouse and guinea-pig preparations. Eur J Pharmacol 704: 49-57, 2013.
67. 2+ channel function. J Cell Biol 169: 435-445, 2005.
68. Schlöndorff D, Bana B. The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20: 1179-1187, 2009.
69. Scindia YM, Deshmukh US, Bagavant H. Mesangial pathology in glomerular disease: targets for therapeutic intervention. Adv Drug Deliv Rev 62: 1337-1343, 2010.
70. 2+ signal generation in A7r5 smooth muscle cells. J Biol Chem 280: 39786-39794, 2005.
71. Song JH, Jung SY, Hong SB, Kim MJ, Suh CK. Effects of high glucose on basal intracellular calcium regulation in rat mesangial cell. Am J Nephrol 23: 343-352, 2003.
72. Sours S, Du J, Chu S, Zhou JX, Ding M, Ma R. Expression of canonical transient receptor potential (TRPC) proteins in human glomerular mesangial cells. Am J Physiol Renal Physiol 290: F1507-F1515, 2006.
73. 2+ entry in mesangial cells. Exp Biol Med 234: 673-682, 2009.
74. Stockand JD, Sansom SC. Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev 78: 723-744, 1998.
75. Sugano M, Yamato H, Hayashi T, Ochiai H, Kakuchi J, Goto S, Nishijima F, Lino N, Kazama JJ, Takeuchi T, Mokuda O, Ishikawa T, Okazaki R. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy. Nutr Metab Cardiovasc Dis 16: 477-484, 2006.
76. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
77. Trebak M, Bird GS, Mckay RR, Putney JW Jr. Comparison of human TRPC3 channels in receptor-activated and store-operated modes Differential sensitivity to channel blockers suggests fundamental differences in channel composition. J Biol Chem 277: 21617-21623, 2002.
78. 2+ entry. Science 312: 1220-1223, 2006.
79. Voelkers M, Salz M, Herzog N, Frank D, Dolatabadi N, Frey N, Gude N, Friedrich O, Koch WJ, Katus HA, Sussman MA, Most P. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. J Mol Cell Cardiol 48: 1329-1334, 2010.
80. Wang Y, Deng X, Gill DL. Calcium signaling by STIM and Orai: intimate coupling details revealed. Sci Signal 3: pe42-1-pe42-4, 2010.
81. Wang Y, Ding M, Chaudhari S, Ding Y, Yuan J, Stankowska D, He S, Krishnamorthy R, Cunningham JT, Ma R. Nuclear factor κB mediates suppression of canonical transient receptor potential 6 expression by reactive oxygen species and protein kinase C in kidney cells. J Biol Chem 288: 12852-12865, 2013.
82. Weigert C, Sauer U, Brodbeck K, Pfeiffer A, Häring HU, Schleicher ED. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-β1 promoter in mesangial cells. J Am Soc Nephrol 11: 2007-2016, 2000.
83. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 90: 248-250, 2002.
84. Whiteside CI, Hurst RD, Stevanovic ZS. Calcium signaling and contractile response of diabetic glomerular mesangial cells. Kidney Int 48: S28-S33, 1995.
85. Williams RT, Manji SSM, Parker NJ, Hancock MS, van Stekelenburg L, Eid JP, Senior PV, Kazenwadel J, Shandala T, Saint R, Smith PJ. Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins. Biochem J 357: 673-685, 2001.
86. Zbidi H, Lopez JJ, Amor NB, Bartegi A, Salido GM, Rosado JA. Enhanced expression of STIM1/Orai1 and TRPC3 in platelets from patients with type 2 diabetes mellitus. Blood Cells Mol Dis 43: 211-213, 2009.
87. 2+ channel activity. Proc Natl Acad Sci USA 103: 9357-9362, 2006.
88. Ziyadeh FN, Sharma K. Role of transforming growth factor-β in diabetic glomerulosclerosis and renal hypertrophy. Kidney Int 48: S34-S36, 1995.